Why is Parmax Pharma falling/rising?

As of 04-Jul, Parmax Pharma Ltd's stock price is currently at Rs 38.75, reflecting a decline of Rs 1.25 or 3.12%. Today's price summary indicates that the stock opened with a gain of 4.55% but subsequently fell to a day's low of Rs 38.75, underperforming its sector by 3.64%. Despite having generated a return of 19.86% over the past year, the company faces challenges with a negative book value and weak long-term fundamental strength, as evidenced by a poor EBIT to interest ratio of 0.66. While net sales have shown significant growth, the company's operating profit has been negative, contributing to the stock's recent downward movement.
In the broader market context, Parmax Pharma's short-term performance over the past week shows a gain of 1.92%, contrasting with the Sensex's decline of 0.74%. However, the stock's performance over the last month has been disappointing, with a decline of 7.07% compared to the Sensex's increase of 3.01%. This underperformance in the short term, coupled with the company's weak long-term growth prospects and negative operating profits, suggests that investor sentiment may be cautious, contributing to the stock's current decline.